Late-onset Sepsis and Development
Launched by NIGDE OMER HALISDEMIR UNIVERSITY · Mar 13, 2025
Trial Information
Current as of April 29, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how late-onset sepsis, an infection that can occur in newborns after the first few days of life, affects motor skills and sensory processing in infants. Researchers want to understand how babies who have had this kind of sepsis develop compared to healthy babies who have not experienced sepsis. They will focus on infants aged 10 to 18 months, a crucial time when children start moving around more and exploring their surroundings.
To participate in the study, infants must be term (born on time) or post-term babies who have had late-onset sepsis. However, the study will not include infants who were born premature or those with certain medical conditions. Families whose infants qualify will have the opportunity to help researchers learn more about the impacts of late-onset sepsis on development, ultimately helping to improve care for future infants.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Term infants with a history of late-onset sepsis
- • Post-term infants between 10-18 months
- Exclusion Criteria:
- • History of early neonatal sepsis,
- • Preterm infants,
- • Those with congenital infection or proven genetic alterations,
- • Infants diagnosed with metabolic, neurological and genetic diseases,
- • Children whose parents do not volunteer for the study
About Nigde Omer Halisdemir University
Nigde Omer Halisdemir University is a distinguished academic institution dedicated to advancing healthcare through innovative research and clinical trials. Committed to fostering a collaborative environment, the university brings together a multidisciplinary team of experts to conduct high-quality clinical research aimed at improving patient outcomes and contributing to medical knowledge. With state-of-the-art facilities and a focus on ethical practices, Nigde Omer Halisdemir University strives to enhance the understanding of various health conditions while promoting evidence-based treatments to benefit the broader community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nigde, , Turkey
Patients applied
Trial Officials
Rabia ZORLULAR
Principal Investigator
Nigde Omer Halisdemir University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported